1. An Interview with Dan Bell - Clinical Trial Supply Europe

  2. An Interview with Sue Lee - Clinical Trial Supply Europe

  3. An Interview with Robert Donnell - Clinical Trial Supply Europe

  4. Clinical Trial Supply: Top 10 Statistics

  5. Weird and Wonderful Pharma Facts

  6. Clinical Trial Supply Europe Video Preview

  7. The Top 10 Trends that will Shape Pharma

  8. Welcome message from the Editor - Cold Chain IQ

  9. Introduction to Pharma IQ

  10. Interview with Bertan Halil

  11. Ariette Van Strien Interview - Clinical Trial Supply Europe

  12. Steve Jacobs Interview - Clinical Trial Supply Europe

  13. Bill Skinner & Toby Winchester, Pfizer: The Smaller the Better -- Compound Management Goes 'Nano'

  14. Robert Schmitt, Abbott: Delivering Compounds to Evolving Drug Discovery Departments

  15. Duncan McHale, AstraZeneca: The Road To Personlised Medicine

  16. Neal Mullen: Some Secrets to Success of iPad Application in E-Health

  17. Marc Descamps: The Rise of Academic/Industry Collaboration in Amorphous Material Studies

  18. Graham White: Flexible Recruitment Approaches to Keep Ahead in the Race for Talent

  19. Global Pharma Contract Manufacturing for Pharma & Bio: Trailer

  20. Why should you work with Pharma IQ?

  21. Fergus Sweeney, EMA: Increasing Inspection Coverage in the Wake of Globalisation

  22. Dr. Yves Juillet, DIA President - Top 3 Regulations Impacting Pharma in 2011 - 2012

  23. Valea Video Series - Introduction to Valea

  24. Valea Video Series - An Overview

  25. Valea Video Series - Mechanics

  26. Valea Video Series - Life Sciences & Chemistry

  27. Valea Video Series - Legal Services

  28. Dr Ronald Frank, Leibniz, FMP: EU Openscreen

  29. Tenna Juul Schrøder, Lundbeck: Outsourcing Parts of your Compound Management Strategy

  30. Oliver Peter PhD, Actelion: Compounds, Biosamples and Materials Management

  31. Jose A. Quiroz, Dart Neuroscience: Compound Informatics and research Information

  32. Andrew Owen, MRC: Developments in Pharmacogenetics & Drug Transporters

  33. Chris Brogan: Which Social Networks Should You Use?

  34. Chris Brogan: What is PharmaWall?

  35. Chris Brogan: Make Your Patient the Hero

  36. Chris Brogan: Listening To Patients with Social Media

  37. Chris Brogan: Connections, Referrals, Awareness, Presence in Social Media in Pharma

  38. David Elder, GSK: Drug Discovery [Part 4] The Rise of Amorphous

  39. David Elder, GSK: Drug Discovery [Part 2] Critical thoughts on Stability

  40. David Elder, GSK: Drug Discovery [Part 5] Considering Genotoxic and Carcinogenic Impurities

  41. David Elder, GSK: Drug Discovery [Part 3] The Focus on Solubility

  42. David Elder, GSK: Drug Discovery [Part 1] An Overview of Externalisation in the Pharma Industry